2014 Opportunities in the US Therapeutic Drug Monitoring (TDM) Market
This new 249-page report from Venture Planning Group provides a comprehensive analysis of the US therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.
During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
“2013 Therapeutic Drug Monitoring (TDM) Market in the US: Hospitals, Commercial Labs, Physician Offices” is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Contains 249 pages and 19 tables
The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.
During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
“2013 Therapeutic Drug Monitoring (TDM) Market in the US: Hospitals, Commercial Labs, Physician Offices” is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Contains 249 pages and 19 tables
INTRODUCTION
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Therapeutic Drug Monitoring Tests
1. Overview
2. Carbamazepine
3. Cyclosporin
4. Digoxin
5. Everolimus
6. Gentamicin
7. Lamotrigine/Lamictal
8. Levetiracetam
9. Lidocaine
10. Lithium
11. Phenytoin
12. NAPA/Procainamide
13. Quinidine
14. Sirolimus
15. Tacrolimus
16. Topirimate
17. Theophylline
18. Valproic Acid
B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers manufactured by Abaxis, Abbott, Alere/Inverness, Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba, Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox, Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
C. Major In Vitro Diagnostic Technologies And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
D. Market Size, Growth and Major Supplier Shares
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott Laboratories
AdnaGen
Agilent Technologies
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Eiken
Fujirebio/Innogenetics
Instrumentation Laboratory
Kyowa Medex
Matritech/Alere
Ortho-Clinical Diagnostics
Quest Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Therapeutic Drug Monitoring Tests
1. Overview
2. Carbamazepine
3. Cyclosporin
4. Digoxin
5. Everolimus
6. Gentamicin
7. Lamotrigine/Lamictal
8. Levetiracetam
9. Lidocaine
10. Lithium
11. Phenytoin
12. NAPA/Procainamide
13. Quinidine
14. Sirolimus
15. Tacrolimus
16. Topirimate
17. Theophylline
18. Valproic Acid
B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers manufactured by Abaxis, Abbott, Alere/Inverness, Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba, Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox, Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
C. Major In Vitro Diagnostic Technologies And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
D. Market Size, Growth and Major Supplier Shares
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott Laboratories
AdnaGen
Agilent Technologies
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Eiken
Fujirebio/Innogenetics
Instrumentation Laboratory
Kyowa Medex
Matritech/Alere
Ortho-Clinical Diagnostics
Quest Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE
LIST OF TABLES
Major Companies Developing or Marketing TDM Tests
Major Companies Developing or Marketing Digoxin Tests
Major Companies Developing or Marketing Lithium Tests
Major Companies Developing or Marketing Phenytoin Tests
Major Companies Developing or Marketing Theophylline Tests
Major Companies Developing or Marketing Valproic Tests
Major Companies Developing or Marketing Biosensors for Genetic Disease Testing
U.S.A., Laboratories Performing TDM Tests By Market Segment
U.S.A., Hospital Laboratories Performing TDM Tests By Bed Size
U.S.A., Commercial/Private Laboratories Performing TDM Tests By Annual Test Volume
U.S.A., TDM Test Volume Forecast By Market Segment
U.S.A., Hospital Laboratories, TDM Test Volume Forecast by Assay
U.S.A., Commercial/Private Laboratories, TDM Test Volume Forecast by Assay
U.S.A., Physician Offices/Group Practices, TDM Test Volume Forecast by Assay
U.S.A., TDM Reagent Market Forecast By Market Segment
U.S.A., Hospital Laboratories, TDM Reagent Market Forecast by Assay
U.S.A., Commercial/Private Laboratories, TDM Reagent Market Forecast by Assay
U.S.A., Physician Office/Group Practices, TDM Reagent Market Forecast by Assay
U.S.A., Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
Major Companies Developing or Marketing TDM Tests
Major Companies Developing or Marketing Digoxin Tests
Major Companies Developing or Marketing Lithium Tests
Major Companies Developing or Marketing Phenytoin Tests
Major Companies Developing or Marketing Theophylline Tests
Major Companies Developing or Marketing Valproic Tests
Major Companies Developing or Marketing Biosensors for Genetic Disease Testing
U.S.A., Laboratories Performing TDM Tests By Market Segment
U.S.A., Hospital Laboratories Performing TDM Tests By Bed Size
U.S.A., Commercial/Private Laboratories Performing TDM Tests By Annual Test Volume
U.S.A., TDM Test Volume Forecast By Market Segment
U.S.A., Hospital Laboratories, TDM Test Volume Forecast by Assay
U.S.A., Commercial/Private Laboratories, TDM Test Volume Forecast by Assay
U.S.A., Physician Offices/Group Practices, TDM Test Volume Forecast by Assay
U.S.A., TDM Reagent Market Forecast By Market Segment
U.S.A., Hospital Laboratories, TDM Reagent Market Forecast by Assay
U.S.A., Commercial/Private Laboratories, TDM Reagent Market Forecast by Assay
U.S.A., Physician Office/Group Practices, TDM Reagent Market Forecast by Assay
U.S.A., Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
